Equities
Real EstateReal Estate Investment Trusts
  • Price (GBX)107.10
  • Today's Change-0.80 / -0.74%
  • Shares traded7.62m
  • 1 Year change+16.73%
  • Beta0.9706
Data delayed at least 15 minutes, as of Feb 16 2026 16:28 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

Primary Health Properties PLC (PHP:LSE) set a new 52-week high during today's trading session when it reached 108.50. Over this period, the share price is up 12.26%.
52-week range
Today
87.40Oct 09 2025108.50Feb 16 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open108.40
High108.40
Low106.70
Bid102.10
Offer108.30
Previous close107.90
Average volume10.92m
Shares outstanding2.60bn
Free float2.53bn
P/E (TTM)16.66
Market cap2.80bn GBP
EPS (TTM)0.0648
GBP
Annual div (ADY)6.65
GBX
Annual div yield (ADY)6.63%
Div ex-dateJan 29 2026
Div pay-dateMar 13 2026
Data delayed at least 15 minutes, as of Feb 16 2026 16:28 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Primary Health Properties PLC shares was Buy at 91.00 on 28 Feb 2025Read the full article

Board of Directors

1/8

Harry Hyman, Non-Executive Chairman

2/8

Mark Davies, Chief Executive Officer

3/8

Richard Howell, Chief Financial Officer

4/8

Laure Duhot, Independent Non-Executive Director

5/8

Ian Krieger, Senior Independent Non-Executive Director

6/8

Ivonne Cantu, Independent Non-Executive Director

7/8

Dr Bandhana (Bina) Rawal, Independent Non-Executive Director

8/8

Jonathan Davies, Independent Non-Executive Director

Contact

London Office:
Fifth floor
Burdett House
15-16 Buckingham Street
London
WC2N 6DU

T: 020 3824 1841

Stratford-upon-Avon Office:
Regional office
First floor
Unit 6, The Courtyard
Timothys Bridge Road
Stratford-upon-Avon
CV37 9NP

T: 01789 263000

2024 Full Year Results

Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.